Cannabis is set to be legalized for the treatment of several medical conditions in Ireland.
Medicinal cannabis could be provided to specific categories of patients with multiple sclerosis, severe epilepsy and those suffering intractable nausea and vomiting associated with chemotherapy, according to the recommendation of the expert working group.
The new medical cannabis scheme will run for five years and will be constantly monitored by Irish health service experts.
The Health Products Regulatory Authority (HPRA) report advises that, if a policy decision is taken to permit cannabis under an access program, it should be for the treatment of patients with:
- Spasticity associated with multiple sclerosis resistant to all standard therapies and interventions whilst under expert medical supervision
- Intractable nausea and vomiting associated with chemotherapy, despite the use of standard anti-emetic regimes whilst under expert medical supervision
- Severe, refractory (treatment-resistant) epilepsy that has failed to respond to standard anticonvulsant medications whilst under expert medical supervision.
- Cannabis Industry
- Cannabis Market
- Cannabis Start-Up